Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
15.26 USD | +0.56% |
|
+1.43% | -9.13% |
05/06 | Catalyst Pharmaceuticals Insider Sold Shares Worth $276,735, According to a Recent SEC Filing | MT |
30/05 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.13% | 1.79B | |
+2.22% | 93.53B | |
-1.32% | 38.27B | |
-13.63% | 32.84B | |
+76.30% | 27.83B | |
-12.91% | 16.08B | |
+1.08% | 14.02B | |
-12.06% | 11.47B | |
+185.28% | 9.92B | |
-53.00% | 9.42B |
- Stock Market
- Equities
- CPRX Stock
- News Catalyst Pharmaceuticals, Inc.
- Transcript : Catalyst Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024